The rating downgrade was based on a number of factors, including KDMC’s continued significant volume and revenue declines, driving greater-than-expected operating losses in fiscal year 2015, which Moody’s expects to continue.
The outlook is negative, reflecting ongoing challenges related to volume losses, physician departures and legal fees.
More articles on finance:
RCM tip of the day: Simplify coding
5 most-read finance stories: Week of Aug. 3-7
Finding new solutions for uncompensated care in a post-reform era
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
